/ Print /

LATEST

Study defines ‘low-value care,’ evaluates toll on healthcare industryA new study led by UCLA researchers has eye-opening findings about low-cost, high-volume unnecessary healthcare. These low-value services may surprise you.
Federal program aimed at reducing readmissions raises concernsA new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.
How treating opioid use disorder is cost effectiveA commercial health plan analysis by axialHealthcare has interesting findings about funding opioid use disorder treatment plans.
Four ways to embrace patient consumerismHere’s how health systems can provide patients with ways to improve their overall financial experience as the frustration around high-deductible health plans continue to encourage patient consumerism.
Top five strategies for managing post-acute carePlans must be able to deploy these five tactics, whether using internal resources or collaborating with a vendor.
Patient experience with immunotherapy: 4 things health execs need to knowCAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.
Top five technology investment areas for healthcare organizationsA new survey from SAP/Oxford Economics has eye-opening findings about the progress of healthcare’s digital transformations.
Two asthma treatment recommendations for health organizationsAllergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.
Why MS relapse rates are underreported: What health execs should knowTwo patient survey studies sponsored by Mallinckrodt reveal findings about patient-reported multiple sclerosis rates.
ICER-VA alliance for formulary management sparks debateThe National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.